Dr. Bin Chen is an accomplished Associate Professor at Michigan State University, specializing in the application of artificial intelligence, machine learning, and big data analytics to biomedical research. His primary research interests lie in computational drug discovery, drug repositioning, and precision medicine. Dr. Chen's work involves developing novel algorithms and computational tools to analyze complex biological data (e.g., genomics, transcriptomics, proteomics) and clinical data to identify new therapeutic uses for existing drugs, predict drug efficacy and toxicity, and understand disease mechanisms. He is dedicated to translating data-driven insights into tangible advancements in healthcare and is actively involved in mentoring students and postdoctoral researchers in these cutting-edge fields. His lab, the 'Chen Lab' at MSU, focuses on 'Big Data, AI, and Drug Discovery'.
Bin Chen's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Awarded the prestigious National Science Foundation (NSF) CAREER Award, recognizing his potential as an early-career faculty member to serve as an academic role model in research and education and to lead advances in the mission of his department or organization. His project focuses on AI-driven drug repositioning.
Has made significant contributions to the field of drug repurposing using computational methods, including developing innovative algorithms and databases (e.g., 'repoDB') that integrate various data sources to predict new uses for existing drugs, potentially accelerating therapeutic development.
Authored and co-authored numerous peer-reviewed publications in high-impact journals and conference proceedings, showcasing his significant contributions to bioinformatics, computational biology, and AI in medicine. His work is frequently cited, indicating a strong influence in his research areas.
Led the development of several publicly available bioinformatics tools and databases that aid researchers worldwide in drug discovery and biomedical data analysis, fostering collaboration and open science.
Successfully secured substantial research funding as a Principal Investigator (PI) or co-PI from major funding agencies like the NIH and NSF, supporting his innovative research program.
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Sabre Holdings (commonly known as Sabre Corporation) is a leading technology provider to the global travel industry. Its software, data, mobile, and distribution solutions are used by hundreds of airlines and thousands of hotel properties to manage critical operations, including passenger and guest reservations, revenue management, and flight, network, and crew management. Sabre also operates a leading global travel marketplace, which processes an estimated $120 billion of global travel spend annually by connecting travel buyers and suppliers.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.